Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 31;6(1):484.
doi: 10.4102/ajlm.v6i1.484. eCollection 2017.

Implementation of Broad Screening With Ebola Rapid Diagnostic Tests in Forécariah, Guinea

Affiliations
Free PMC article

Implementation of Broad Screening With Ebola Rapid Diagnostic Tests in Forécariah, Guinea

Frantz Jean Louis et al. Afr J Lab Med. .
Free PMC article

Abstract

Background: Laboratory-enhanced surveillance is critical for rapidly detecting the potential re-emergence of Ebola virus disease. Rapid diagnostic tests (RDT) for Ebola antigens could expand diagnostic capacity for Ebola virus disease.

Objectives: The Guinean National Coordination for Ebola Response conducted a pilot implementation to determine the feasibility of broad screening of patients and corpses with the OraQuick® Ebola RDT.

Methods: The implementation team developed protocols and trained healthcare workers to screen patients and corpses in Forécariah prefecture, Guinea, from 15 October to 30 November 2015. Data collected included number of consultations, number of fevers reported or measured, number of tests performed for patients or corpses and results of confirmatory RT-PCR testing. Data on malaria RDT results were collected for comparison. Feedback from Ebola RDT users was collected informally during supervision visits and forums.

Results: There were 3738 consultations at the 15 selected healthcare facilities; 74.6% of consultations were for febrile illness. Among 2787 eligible febrile patients, 2633 were tested for malaria and 1628 OraQuick® Ebola RDTs were performed. A total of 322 OraQuick® Ebola RDTs were conducted on corpses. All Ebola tests on eligible patients were negative.

Conclusions: Access to Ebola testing was expanded by the implementation of RDTs in an emergency situation. Feedback from Ebola RDT users and lessons learned will contribute to improving quality for RDT expansion.

Conflict of interest statement

The authors declare that they have no financial or personal relationships which may have inappropriately influenced them in writing this article.

Figures

FIGURE 1
FIGURE 1
OraQuick® Ebola RDT pilot study implementation strategies in Forécariah, Guinea, 15 October to 30 November 2015.
FIGURE 2
FIGURE 2
Map of health facilities selected for the OraQuick® Ebola RDT pilot in Forécariah†.

Similar articles

See all similar articles

Cited by 4 articles

References

    1. World Health Organization Emergencies preparedness, response: Ebola maps 2015 [page on the Internet]. c2015 [cited 2015 Dec]. Available from: https://www.who.int/csr/disease/ebola/maps-2015/en/
    1. Diers J, Kouriba B, Ladan Fofana L, et al. [Mobile laboratories for rapid deployment and their contribution to the containment of emerging diseases in Sub-Saharan Africa, illustrated by the example of Ebola virus disease] [article in French]. Med Sante Trop. 2015;25(3):229–233. https://doi.org/10.1684/mst.2015.0485 - DOI - PubMed
    1. Nouvellet P, Garske T, Mills HL, et al. The role of rapid diagnostics in managing Ebola epidemics. Nature. 2015;528(7580):S109–116. https://doi.org/10.1038/nature16041 - DOI - PMC - PubMed
    1. World Health Organization Urgently needed: rapid, sensitive, safe and simple Ebola diagnostic tests [page on the Internet]. c2014 [cited 2015 Dec]. Available from: https://www.who.int/mediacentre/news/ebola/18-november-2014-diagnostics/en/
    1. Broadhurst MJ, Kelly JD, Miller A, et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;386(9996):867–874. https://doi.org/10.1016/S0140-6736(15)61042-X - DOI - PubMed

LinkOut - more resources

Feedback